Furthermore, in triple negative breast cancer (TNBC) and colorectal cancer (CRC), inhibition of POLR2A has a selective inhibitory effect on the growth of tumors with loss of POLR2A hemizygotes. Here, POLR2A is linked to colorectal carcinoma.